InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Vachon Mark, 董事. Officer active across 1 company, notably bluebird bio, Inc.. Cumulatively, 6 disclosures have been logged. History available since 15 June 2021. The latest transaction was filed on 6 November 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Vachon Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
1,252 股Common StockSEC:0000950170-25-081156:0
24,900 股0Common StockSEC:0001562180-24-007603:0
10,790 股0Common StockSEC:0001562180-23-005352:0
4,353 股0Common StockSEC:0001562180-22-005338:0
6,241 股0Common StockSEC:0001628280-21-023458:0
3,109 股0Common StockSEC:0001562180-21-004356:0
6 条申报中的 6 条
About Vachon Mark
Mark Vachon is a Board Member at bluebird bio, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector allows him to bring valuable insights to the management team. Mark is committed to supporting bluebird bio's mission to develop innovative therapies for genetic diseases.
